English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/143467
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


VE-cadherin RGD motifs promote metastasis and constitute a potential therapeutic target in melanoma and breast cancers

AuthorsBartolomé, Rubén Álvaro ; Torres, Sofía ; Isern de Val, Soledad; Escudero-Paniagua, B. ; Calviño, Eva ; Teixidó, Joaquín ; Casal, J. Ignacio
RGD motif
Breast cancer
Issue Date9-Dec-2016
PublisherImpact Journals
CitationOncotarget 8 (1) 215-227 (2017)
AbstractWe have investigated the role of vascular-endothelial (VE)-cadherin in melanoma and breast cancer metastasis. We found that VE-cadherin is expressed in highly aggressive melanoma and breast cancer cell lines. Remarkably, inactivation of VEcadherin triggered a significant loss of malignant traits (proliferation, adhesion, invasion and transendothelial migration) in melanoma and breast cancer cells. These effects, except transendothelial migration, were induced by the VE-cadherin RGD motifs. Co-immunoprecipitation experiments demonstrated an interaction between VE-cadherin and α2β1 integrin, with the RGD motifs found to directly affect β1 integrin activation. VE-cadherin-mediated integrin signaling occurred through specific activation of SRC, ERK and JNK, including AKT in melanoma. Knocking down VEcadherin suppressed lung colonization capacity of melanoma or breast cancer cells inoculated in mice, while pre-incubation with VE-cadherin RGD peptides promoted lung metastasis for both cancer types. Finally, an in silico study revealed the association of high VE-cadherin expression with poor survival in a subset of melanoma patients and breast cancer patients showing low CD34 expression. These findings support a general role for VE-cadherin and other RGD cadherins as critical regulators of lung and liver metastasis in multiple solid tumours. These results pave the way for cadherin-specific RGD targeted therapies to control disseminated metastasis in multiple cancers.
Description13 p.-6 fig.
Publisher version (URL)http://dx.doi.org/10.18632/oncotarget.13832
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
ONCOTARGET 2017.pdfArtículo principal6,5 MBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.